Jonathan Kurtis
9Patents
3h-index
10Co-inventors
50Inventor score
Filing activity: Nov 5, 2008 → May 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10213502B2 | Vaccine for falciparum malaria | Emerging Cross-Sectional Technologies | 3 | Active |
| US9662379B2 | Vaccine for falciparum malaria | Emerging Cross-Sectional Technologies | 3 | Active |
| US10272145B2 | Vaccine for falciparum malaria | Emerging Cross-Sectional Technologies | 3 | Active |
| US10960065B2 | Vaccine for falciparum malaria | Emerging Cross-Sectional Technologies | 1 | Active |
| US11692026B2 | Antibodies to PfGARP kill Plasmodium falciparum malaria parasites and protect against infection and severe disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US12037386B2 | Antibodies to PfGARP kill Plasmodium falciparum malaria parasites and protect against infection and severe disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US9283264B2 | Schistosoma vaccine | Human Necessities | 0 | Active |
| US11554165B2 | Vaccine for falciparum malaria | Emerging Cross-Sectional Technologies | 0 | Active |
| US12214026B2 | Vaccine for falciparum malaria | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.